Gastrointestinals & Health Through Digestion
Gastrointestinals, Probiotics & the Evolving Market for Health Through Digestion
The global market for Gastrointestinals plus Probiotics expanded by 3.6% in the 12 months to mid-2020 to nearly $22bn; it is set to be worth over $33bn by 2029. It is being driven by modern lifestyles (often characterised by irregular unhealthy eating patterns and increased alcohol intake), rising consumer understanding of digestive conditions, limited but important launch activity, and wider acceptance of the health benefits of probiotics. Holding back growth are ingredient restrictions in selected markets and categories, brands facing competition from private labels & generics, and a lack of innovation in certain mature categories.
Health Through Digestion is one of the hottest topics in consumer healthcare. The gut microbiome is of central importance in maintaining the body's natural defences and boosting overall wellness. A host of products, primarily probiotics, prebiotics and synbiotics, offer gut health-related benefits beyond digestion such as immunity, weight management, mood & stress, skin health, and more. Ongoing research into the gut-brain axis (the biochemical signal between GI tract and central nervous system) casts fresh light on the expanding role of gut flora in health.
Covering all the issues affecting the GIs and Probiotics market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report spans 10 in-depth country profiles (generating over 70% of global sales between them) with insights and predictions, plus mini-profiles of additional markets .
New product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, line extensions, new benefits and more.
As part of the global overview, this report digs into the latest trends & developments in Health through digestion , including food intolerance and adult & infant nutrition.
† selected markets only.
Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.
The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances. Sales cover 12 months to mid-year 2020 (and mid-2019), plus historical growth rates back to 2015. The latest short-term forecasts to 2020 & 2021 and longer-term forecasts to 2024 & 2029 for each market and category are included.
Segmentation of sales in selected categories, including antacids, laxatives and probiotics, helps give a more detailed picture of each market.
PLUS coverage of selected additional markets in brief.